Related content

Receptor Activator of Nuclear Factor-B Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis

By Sasaki Atsushi   Ishikawa Kenji   Haraguchi Naotsugu   Inoue Hiroshi   Ishio Tetsuya   Shibata Kohei   Ohta Masayuki   Kitano Seigo   Mori Masaki  

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1191-1199

Springer Publishing Company

Access to resources Recommend Favorite

Cadmium induces urokinase-type plasminogen activator receptor expression and the cell invasiveness of human gastric cancer cells via the ERK-1/2, NF-κB, and AP-1 signaling pathways

By                  

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1760-1768

Spandidos Publications

Access to resources Recommend Favorite

Orostachys japonicus inhibits the expression of MMP-2 and MMP-9 mRNA and modulates the expression of iNOS and COX-2 genes in human PMA-differentiated THP-1 cells via inhibition of NF-κB and MAPK activation

By              

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 657-662

Spandidos Publications

Access to resources Recommend Favorite

Andrographolide inhibits multiple myeloma cells by inhibiting the TLR4/NF-κB signaling pathway

By    

Molecular Medicine Reports, Vol. 13, Iss. 2, 2016-01 ,pp. : 1827-1832

Spandidos Publications

Access to resources Recommend Favorite

Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)

By    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3212-3218

Spandidos Publications

Access to resources Recommend Favorite